Patent Attorney
TEL |
+82-2-6386-7962 |
E-MAIL |
mee.son@leekoip.com |
|
|
Since becoming a patent lawyer in 2013, Mee Son has successfully handled a number of IP matters, including patent prosecution matters and IP disputes, as well as opinions of counsel relating to biological, pharmaceutical, and chemical technologies. She has extensive experience in prosecuting patents over a wide range of biological and chemical technologies involving antibodies, stem cells, enzymes, peptides, vaccines, organic compounds, films, and resin compositions. She also has experience dealing with patent listings, Patent Term Extension (PTE) applications, petitions prohibiting the sale of medicine to the MFDS, and procedures for plant variety protection (PVP) to the KSVS.
Mee Son obtained a Master's degree and a Ph.D. regarding the study of α-glucosidase at Hokkaido University (JP), and studied enzymes for one year in the Molecular Enzymology laboratory at the same institution. In addition, she has researched the preparation of human plasma proteins for proteomic analysis and the cytotoxic effect of TCDD at the College of Medicine of Korea University.
Education
2002 |
Hokkaido University (JP) – Ph.D. in Applied Life Sciences |
1999 |
Hokkaido University (JP) - M.A. in Applied Life Sciences |
1997 |
Chonnam National University - B.A. in Biochemical engineering |
Work Experience
2020-Present |
Lee & Ko IP |
2018-2020 |
NAM & NAM Patent Firm |
2017-2018 |
WON International Patent & Law Firm |
2014-2017 |
KOREANA Patent Firm |
Expertise
Chemical |
Pharmaceuticals · Biotechnology |
IPTAB Proceedings |
US · Europe (IP Prosecution) |
Japan (IP Prosecution) |
IP Litigation |
Healthcare · Life Sciences |
IP Strategy Consulting |
Admissions
Admitted to the Korean patent bar (2013) |
Languages
Korean, English and Japanese |
Representative Cases
- Third-party observations against applications regarding resin compositions
- License registrations to the Korean Intellectual Property Office (KIPO), Patent Term Extension (PTE) applications
- Petition for the prohibition of sales of generic medicines to the MFDS
- Scope confirmation trials regarding drugs for treating idiopathic pulmonary fibrosis
- Freedom-to-Operate (FTO) analyses on patent infringement regarding CAR-T cells
- FTO analysis on patent infringement regarding pharmaceutical composition for treating inflammatory disease
- FTO analysis on patent infringement regarding knock-out mouse
- FTO analyses on patent infringement regarding polypropylene, resin compositions
- FTO analyses on patent infringement, invalidity analyses of the patent and patent invalidity actions regarding antibody-related patents
- FTO analyses on patent infringement and legal opinions for licensing regarding stem cells patents
- Patent map regarding CAR T cell
- Patent map regarding biologics
- Plant variety protection applications
- Responding to negative scope confirmation action for patents regarding oral pharmaceutical preparations for the prevention or treatment of allergic rhinitis or asthma
- Appeals and correction trials for patents regarding digestion-resistant carbohydrate
- Cancellation action for patent regarding pre-filled syringe(PFS)
- Legal opinions and patent infringement actions regarding eye disease drug
- Invalidation action against patents regarding bi-specific antibody for treatment of multiple myeloma
- IPTAB trials regarding PTE applications related to myeloproliferative diseases
Publications / Presentations / ETC
- Member of the external advisory committee of the KIPT for system and quality improvement of patent trials: 2017, 2018, 2020